TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide

AIDS

Volumn 25, Issue 2, 2011, Pages 265-269

  Lorente, Elena ^a   Infantes, Susana ^a   Barnea, Eilon ^b   Beer, Ilan ^b   García, Ruth ^a   Lasala, Fátima ^c   Jiménez, Mercedes ^c   Admon, Arie ^b   López, Daniel ^a,c  

^a Unidad de Procesamiento Antigénico   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; HISTOCOMPATIBILITY ANTIGEN; HLA A2 ANTIGEN; HLA B27 ANTIGEN; HLA B51 ANTIGEN; HLA E ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PA2.1; PROTEIN HLA CW1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS ISOLATION;

ATP-BINDING CASSETTE TRANSPORTERS; HLA-C ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN BINDING; VIRAL PROTEINS;

EID: 78650903441     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328340fe3c     Document Type: Article

References (23)

1. York IA, Goldberg AL, Mo XY, Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 1999; 172:49-66.
2. Del Val M, López D. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8R T lymphocytes. Mol Immunol 2002; 39:235-247.
3. Johnstone C, Del Val M. Traffic of proteins and peptides across membranes for immunosurveillance by CD8R T Lymphocytes: a topological challenge. Traffic 2007; 8:1486-1494.
4. Cerundolo V, de la Salle H. Description of HLA class I- and CD8-deficient patients: insights into the function of cytotoxic T lymphocytes and NK cells in host defense. Semin Immunol 2006; 18:330-336.
5. Hammond SA, Bollinger RC, Tobery TW, Siliciano RF. Transporter- independent processing of HIV-1 envelope protein for recognition by CD8R T cells. Nature 1993; 364: 158-161.
6. Hammond SA, Johnson RP, Kalams SA, Walker BD, Takiguchi M, Safrit JT, et al. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8R CTL. J Immunol 1995; 154:6140-6156.
7. Infantes S, Lorente E, Barnea E, Beer I, Cragnolini JJ, Garća R, et al. Multiple, nonconserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics 2010; 9:1533-1539.
8. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986; 5:943-949.
9. Chakrabarti S, Robert-Guroff M, Wong-Staal F, Gallo RC, Moss B. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature 1986; 320:535-537.
10. Parham P, Bodmer WF. Monoclonal antibody to a human his-tocompatibility alloantigen, HLA-A2. Nature 1978; 276:397-399.
11. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 1982; 5:49-59.
12. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, ZieglerA. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978; 14:9-20.
13. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992; 255:1261-1263.
14. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. Human histocompatibility leukocyte antigen-binding super-motifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997; 100:503-513.
15. Kondo E, Akatsuka Y, Kuzushima K, Tsujimura K, Asakura S, Tajima K, et al. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 2004; 103:630-638.
16. Fan QR, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-CW4 class I major histocompatibility complex molecule. Proc Natl Acad Sci USA 1996; 93:7178-7183.
17. López D,SaminoY, Koszinowski UH, Del Val M.HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J Immunol 2001; 167:4238-4244.
18. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95:5199-5204.
19. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-219.
20. Barber LD, Percival L, Valiante NM, Chen L, Lee C, Gumperz JE, et al. The inter-locus recombinant HLA-BM4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J Exp Med 1996; 184:735-740.
21. Suri A, Walters JJ, Levisetti MG, Gross ML, Unanue ER. Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur J Immunol 2006; 36:544-557.
22. Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert P, Schild H, et al. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur J Immunol 2008; 38:1503-1510.
23. Yu B, Fonseca DP, O'Rourke SM, Berman PW. Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites. J Virol 2010; 84:1513-1526.